International immunopharmacology
-
Int. Immunopharmacol. · Oct 2019
Meta AnalysisTreatment of plaque psoriasis with IL-23p19 blockers: A systematic review and meta-analysis.
Interleukin(IL)-23 is a key cytokine in the pathogenesis of psoriasis, this meta-analysis was to analyze the efficacy and safety of IL-23p19 blockers in patients with plaque psoriasis. ⋯ The IL-23p19 blockers have excellent efficacy and great safety in plaque psoriasis patients, but long-term safety remains to be determined.